DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹11 Cr | ₹10 Cr | ₹14 Cr | ₹13 Cr | ₹10 Cr |
What is the latest Contingent Liabilities ratio of DR LAL PATHLABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹10 Cr |
How is Contingent Liabilities of DR LAL PATHLABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 4.99 | |
| Mar2024 | ₹10 Cr | -26.02 | |
| Mar2023 | ₹14 Cr | 3.43 | |
| Mar2022 | ₹13 Cr | 26.43 | |
| Mar2021 | ₹10 Cr | - | |
Compare Contingent Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹27,605.4 Cr | -1.4% | 1.9% | 16.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹124,925.0 Cr | 2.2% | 4.6% | 21.7% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹109,908.0 Cr | 5.2% | 15.6% | -7.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹72,264.6 Cr | -2.4% | -0.9% | 26.4% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹40,662.1 Cr | -3% | 3.4% | 38% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹40,282.6 Cr | -0.1% | -0.9% | 2.9% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -1.4% |
1.9% |
16.2% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses